The present invention provides compositions and methods for the use of
antigenic peptides derived from the Fc portion of the epsilon heavy chain
of IgE molecules from two unrelated species as vaccines for the treatment
and prevention of IgE-mediated allergic disorders. In particular, the
invention provides compositions for the treatment and prevention of
IgE-mediated allergic disorders comprising an immunogenic amount of one
or more antigenic peptides.